
News|Articles|June 1, 2004
New molecular entity: Apomorphine injection
First therapy approved for “off” episodes in advanced Parkinson’s disease
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Overlooked bladder nerves now thought to reduce UTI burden through pain signaling, study shows
2
Cleveland Clinic, Siemens Healthineers expand into 10-year imaging partnership
3
Medicaid expansion linked to improved NSCLC survival, diagnosis
4
FDA approves Pasatru, the second treatment for rare bone disorder
5














